(EFX) Equifax - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2944291051
EFX: Credit, Verification, Analytics, Fraud, Workforce
Equifax Inc. (NYSE: EFX) is a global data, analytics, and technology company specializing in credit bureau services, identity verification, and workforce management solutions. The company operates through three core segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment provides employment verification services, including income, education, and criminal history checks, as well as payroll-related and HR management tools for employers. This includes solutions like The Work Number, which streamlines employment and income verification processes for lenders, landlords, and other stakeholders. The U.S. Information Solutions segment offers consumer and commercial credit information, credit scoring, fraud detection, and identity verification services. It also provides mortgage services, financial marketing, and credit monitoring products, leveraging its proprietary databases to deliver actionable insights. The International segment operates in over 20 countries, offering similar services tailored to local markets, including credit and financial information, debt recovery management, and HR process automation.
Equifax serves a diverse range of customers, including financial institutions, governments, employers, and consumers. Its global footprint spans the Americas, Europe, Asia, and the Pacific, with a strong presence in emerging markets. The company has a long history, dating back to 1899, and is headquartered in Atlanta, Georgia. Equifax is a leader in the credit bureau industry, competing with companies like Experian and TransUnion. Its services are critical for credit decisions, fraud prevention, and workforce management, making it a key player in the global financial ecosystem.
Based on the provided technical and fundamental data, here is a 3-month forecast for Equifax (EFX):
From a technical perspective, EFX is currently trading below its 20-day, 50-day, and 200-day moving averages, indicating bearish momentum. The stock is priced at $215.29, with an ATR of 8.91, suggesting moderate volatility. If the stock fails to break above the 20-day SMA of $228.68, it may test support levels near $200. Conversely, a breakout above $228.68 could signal a potential recovery toward the 50-day SMA of $238.10. The 200-day SMA of $263.96 remains a key resistance level.
Fundamentally, Equifax has a market cap of $27.61 billion, with a trailing P/E of 45.62 and a forward P/E of 29.50, indicating elevated valuations but also reflecting market expectations for future growth. The P/B ratio of 5.76 suggests that the stock is trading at a premium to its book value, while the P/S ratio of 4.86 indicates strong revenue multiples. With an ROE of 12.59%, the company demonstrates solid profitability. Over the next three months, investor focus will likely remain on the companys ability to maintain revenue growth, particularly in its International and Workforce Solutions segments, amid macroeconomic uncertainties. The upcoming earnings report will be a critical catalyst, as will any updates on the companys progress in emerging markets and its debt recovery management solutions.
Additional Sources for EFX Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
EFX Stock Overview
Market Cap in USD | 30,964m |
Sector | Industrials |
Industry | Consulting Services |
GiC Sub-Industry | Research & Consulting Services |
IPO / Inception | 1971-05-11 |
EFX Stock Ratings
Growth Rating | 41.1 |
Fundamental | 31.4 |
Dividend Rating | 40.1 |
Rel. Strength | 7.91 |
Analysts | 4.27/5 |
Fair Price Momentum | 230.43 USD |
Fair Price DCF | 96.86 USD |
EFX Dividends
Dividend Yield 12m | 0.80% |
Yield on Cost 5y | 1.55% |
Annual Growth 5y | 0.00% |
Payout Consistency | 96.1% |
EFX Growth Ratios
Growth Correlation 3m | -62% |
Growth Correlation 12m | -4.1% |
Growth Correlation 5y | 58.1% |
CAGR 5y | 14.00% |
CAGR/Max DD 5y | 0.28 |
Sharpe Ratio 12m | 0.12 |
Alpha | 2.28 |
Beta | 1.153 |
Volatility | 48.12% |
Current Volume | 1118.4k |
Average Volume 20d | 1293.5k |
As of April 28, 2025, the stock is trading at USD 256.48 with a total of 1,118,421 shares traded.
Over the past week, the price has changed by +19.13%, over one month by +5.20%, over three months by -6.56% and over the past year by +14.42%.
Neither. Based on ValueRay Fundamental Analyses, Equifax is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 31.42 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EFX as of April 2025 is 230.43. This means that EFX is currently overvalued and has a potential downside of -10.16%.
Equifax has received a consensus analysts rating of 4.27. Therefor, it is recommend to buy EFX.
- Strong Buy: 11
- Buy: 6
- Hold: 5
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, EFX Equifax will be worth about 261 in April 2026. The stock is currently trading at 256.48. This means that the stock has a potential upside of +1.75%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 278.1 | 8.4% |
Analysts Target Price | 310.6 | 21.1% |
ValueRay Target Price | 261 | 1.8% |